+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Animal Therapeutics and Diagnostics Market By Product Type, By Animal Type: Global Opportunity Analysis and Industry Forecast, 2020-2030

  • PDF Icon

    Report

  • 188 Pages
  • March 2022
  • Region: Global
  • Allied Market Research
  • ID: 5640400
Description Jump to:
The global animal therapeutics and diagnostics market was valued at $33,462.5 million in 2020, and is projected to reach $59,082.1 million by 2030, registering a CAGR of 5.9% from 2021 to 2030. Animal therapeutics includes a variety of therapeutic items that may be used to treat many diseases. Various tests and techniques are utilized in the diagnosis of any diseases in animals. Both animal diagnostics and animal therapies are critical for illness treatment. The sustainability of animal health becomes increasingly important as human dependency on animals for daily necessities such as meat, protein, and milk grows. Diseases are diagnosed using a variety of diagnostic tests and devices, whereas therapy solutions are administered using medications based on their mechanism of action. Majority of the diagnostic tests and treatment products are required by veterinary clinics.

The market is predicted to grow at a moderate rate throughout the forecast period, owing to increase in knowledge about animal health in livestock and pet animals as well as surge in adoption of companion animals around the world. In addition, rise in meat & milk consumption and alarming increase in prevalence of zoonotic illnesses significantly contribute toward the market expansion. However, high costs of diagnosis and therapeutic treatments and overuse of drugs in animals can have a severe impact on public and animal health, thus hindering the market growth. Furthermore, lack of understanding about animal welfare among pet owners can stifle the growth of the animal diagnostics and therapeutics industry.

Key players in animal therapeutics and diagnostics are launching various test kits and diagnostics kits to monitor animals’ behavior and health. For instance, in October 2021, Zoetis Inc., manufacturer of animal medicines and vaccines, launched digital cytology testing to its Vetscan Imagyst product. In addition to AI technology for fecal testing, Vetscan Imagyst now provides a network of skilled remote pathologists. Furthermore, in June 2021, Zoetis Inc. expanded its equine orse care products by introducing Restigen, PRP, Pro-Stride APS, and CenTrateBMA. These devices are designed to address injuries in horses that may cause limping. Introduction of such products is a key factor fostering the market growth.

The market is segmented into product type, animal type industry, and region. Depending on product type, the market is classified into animal diagnostics products and animal therapeutics products. By animal type, it is classified as companion animals, cattle, pigs, poultry, and sheep. Region wise, the global market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Competition Analysis


The key players operating in the global animal therapeutics and diagnostics are Zoetis Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Virbac, Idexx Laboratories Inc., Ceva Sante Animale, Sanofi S.A., Heska Corporation, Thermo Fisher Scientific Inc., and Randox Laboratories Ltd.

Key Benefits For Stakeholders

  • The report provides an extensive analysis of the current and emerging animal therapeutics and diagnostics market trends and dynamics.
  • In-depth animal therapeutics and diagnostics market analysis is conducted by constructing market estimations for Key Market Segmens
between 2021 and 2030.
  • The global animal therapeutics and diagnostics market share analysis from 2020 to 2030 is included in the report.
  • Extensive analysis of the animal therapeutics and diagnostics market size is conducted by following key product positioning and monitoring of top competitors within the market framework.
  • A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
  • The global animal therapeutics and diagnostics market forecast analysis from 2021 to 2030 is included in the report.
  • The key players which contributed to the animal therapeutics and diagnostics market growth are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the animal therapeutics and diagnostics industry.

Key Market Segments


By Product Type

  • Animal Diagnostics Products
  • Animal Therapeutics Products

By Animal Type

  • Companion Animals
  • Cattle
  • Pigs
  • Poultry
  • Sheep

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players

  • Bayer AG
  • Eli Lilly and Company
  • Boehringer
  • Ingelheim GmbH
  • Merck and Co.
  • Zoetis Inc.
  • Ceva Sante Animale
  • Sanofi S.A.
  • Nutreco N.V.
  • Virbac S.A.

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Top player positioning
3.5. Market dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
3.6. COVID-19 Impact Analysis on the market
CHAPTER 4: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Animal Diagnostics Products
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Animal Therapeutics Products
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY ANIMAL TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Companion Animals
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Cattle
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Pigs
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Poultry
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Sheep
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
CHAPTER 6: ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET, BY REGION
6.1 Overview
6.1.1 Market size and forecast
6.2 North America
6.2.1 Key trends and opportunities
6.2.2 North America Market size and forecast, by Product Type
6.2.3 North America Market size and forecast, by Animal Type
6.2.4 North America Market size and forecast, by country
6.2.4.1 U.S.
6.2.4.1.1 Market size and forecast, by Product Type
6.2.4.1.2 Market size and forecast, by Animal Type
6.2.4.2 Canada
6.2.4.2.1 Market size and forecast, by Product Type
6.2.4.2.2 Market size and forecast, by Animal Type
6.2.4.3 Mexico
6.2.4.3.1 Market size and forecast, by Product Type
6.2.4.3.2 Market size and forecast, by Animal Type
6.3 Europe
6.3.1 Key trends and opportunities
6.3.2 Europe Market size and forecast, by Product Type
6.3.3 Europe Market size and forecast, by Animal Type
6.3.4 Europe Market size and forecast, by country
6.3.4.1 Germany
6.3.4.1.1 Market size and forecast, by Product Type
6.3.4.1.2 Market size and forecast, by Animal Type
6.3.4.2 France
6.3.4.2.1 Market size and forecast, by Product Type
6.3.4.2.2 Market size and forecast, by Animal Type
6.3.4.3 U.K.
6.3.4.3.1 Market size and forecast, by Product Type
6.3.4.3.2 Market size and forecast, by Animal Type
6.3.4.4 Italy
6.3.4.4.1 Market size and forecast, by Product Type
6.3.4.4.2 Market size and forecast, by Animal Type
6.3.4.5 Rest of Europe
6.3.4.5.1 Market size and forecast, by Product Type
6.3.4.5.2 Market size and forecast, by Animal Type
6.4 Asia-Pacific
6.4.1 Key trends and opportunities
6.4.2 Asia-Pacific Market size and forecast, by Product Type
6.4.3 Asia-Pacific Market size and forecast, by Animal Type
6.4.4 Asia-Pacific Market size and forecast, by country
6.4.4.1 China
6.4.4.1.1 Market size and forecast, by Product Type
6.4.4.1.2 Market size and forecast, by Animal Type
6.4.4.2 India
6.4.4.2.1 Market size and forecast, by Product Type
6.4.4.2.2 Market size and forecast, by Animal Type
6.4.4.3 Japan
6.4.4.3.1 Market size and forecast, by Product Type
6.4.4.3.2 Market size and forecast, by Animal Type
6.4.4.4 South Korea
6.4.4.4.1 Market size and forecast, by Product Type
6.4.4.4.2 Market size and forecast, by Animal Type
6.4.4.5 Rest of Asia-Pacific
6.4.4.5.1 Market size and forecast, by Product Type
6.4.4.5.2 Market size and forecast, by Animal Type
6.5 LAMEA
6.5.1 Key trends and opportunities
6.5.2 LAMEA Market size and forecast, by Product Type
6.5.3 LAMEA Market size and forecast, by Animal Type
6.5.4 LAMEA Market size and forecast, by country
6.5.4.1 Latin America
6.5.4.1.1 Market size and forecast, by Product Type
6.5.4.1.2 Market size and forecast, by Animal Type
6.5.4.2 Middle East
6.5.4.2.1 Market size and forecast, by Product Type
6.5.4.2.2 Market size and forecast, by Animal Type
6.5.4.3 Africa
6.5.4.3.1 Market size and forecast, by Product Type
6.5.4.3.2 Market size and forecast, by Animal Type
CHAPTER 7: COMPANY LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Key developments
CHAPTER 8: COMPANY PROFILES
8.1 Bayer AG
8.1.1 Company overview
8.1.2 Company snapshot
8.1.3 Operating business segments
8.1.4 Product portfolio
8.1.5 Business performance
8.1.6 Key strategic moves and developments
8.2 Eli Lilly and Company
8.2.1 Company overview
8.2.2 Company snapshot
8.2.3 Operating business segments
8.2.4 Product portfolio
8.2.5 Business performance
8.2.6 Key strategic moves and developments
8.3 Boehringer
8.3.1 Company overview
8.3.2 Company snapshot
8.3.3 Operating business segments
8.3.4 Product portfolio
8.3.5 Business performance
8.3.6 Key strategic moves and developments
8.4 Ingelheim GmbH
8.4.1 Company overview
8.4.2 Company snapshot
8.4.3 Operating business segments
8.4.4 Product portfolio
8.4.5 Business performance
8.4.6 Key strategic moves and developments
8.5 Merck and Co.
8.5.1 Company overview
8.5.2 Company snapshot
8.5.3 Operating business segments
8.5.4 Product portfolio
8.5.5 Business performance
8.5.6 Key strategic moves and developments
8.6 Zoetis Inc.
8.6.1 Company overview
8.6.2 Company snapshot
8.6.3 Operating business segments
8.6.4 Product portfolio
8.6.5 Business performance
8.6.6 Key strategic moves and developments
8.7 Ceva Sante Animale
8.7.1 Company overview
8.7.2 Company snapshot
8.7.3 Operating business segments
8.7.4 Product portfolio
8.7.5 Business performance
8.7.6 Key strategic moves and developments
8.8 Sanofi S.A.
8.8.1 Company overview
8.8.2 Company snapshot
8.8.3 Operating business segments
8.8.4 Product portfolio
8.8.5 Business performance
8.8.6 Key strategic moves and developments
8.9 Nutreco N.V.
8.9.1 Company overview
8.9.2 Company snapshot
8.9.3 Operating business segments
8.9.4 Product portfolio
8.9.5 Business performance
8.9.6 Key strategic moves and developments
8.10 Virbac S.A.
8.10.1 Company overview
8.10.2 Company snapshot
8.10.3 Operating business segments
8.10.4 Product portfolio
8.10.5 Business performance
8.10.6 Key strategic moves and developments
LIST OF TABLES
Table 1. Global Animal Therapeutics and Diagnostics Market, by Product Type, 2020-2030, ($Million)
Table 2. Animal Therapeutics and Diagnostics Market Revenue, for Animal Diagnostics Products, by Region, 2020-2030, ($Million)
Table 3. Animal Therapeutics and Diagnostics Market Animal Diagnostics Products by Country, 2020-2030, ($Million)
Table 4. Animal Therapeutics and Diagnostics Market Revenue, for Animal Therapeutics Products, by Region, 2020-2030, ($Million)
Table 5. Animal Therapeutics and Diagnostics Market Animal Therapeutics Products by Country, 2020-2030, ($Million)
Table 6. Global Animal Therapeutics and Diagnostics Market, by Animal Type, 2020-2030, ($Million)
Table 7. Animal Therapeutics and Diagnostics Market Revenue, for Companion Animals, by Region, 2020-2030, ($Million)
Table 8. Animal Therapeutics and Diagnostics Market Companion Animals by Country, 2020-2030, ($Million)
Table 9. Animal Therapeutics and Diagnostics Market Revenue, for Cattle, by Region, 2020-2030, ($Million)
Table 10. Animal Therapeutics and Diagnostics Market Cattle by Country, 2020-2030, ($Million)
Table 11. Animal Therapeutics and Diagnostics Market Revenue, for Pigs, by Region, 2020-2030, ($Million)
Table 12. Animal Therapeutics and Diagnostics Market Pigs by Country, 2020-2030, ($Million)
Table 13. Animal Therapeutics and Diagnostics Market Revenue, for Poultry, by Region, 2020-2030, ($Million)
Table 14. Animal Therapeutics and Diagnostics Market Poultry by Country, 2020-2030, ($Million)
Table 15. Animal Therapeutics and Diagnostics Market Revenue, for Sheep, by Region, 2020-2030, ($Million)
Table 16. Animal Therapeutics and Diagnostics Market Sheep by Country, 2020-2030, ($Million)
Table 17. Animal Therapeutics and Diagnostics Market, by Region, 2020-2030, ($Million)
Table 18. North America Animal Therapeutics and Diagnostics Market, by Product Type, 2020-2030, ($Million)
Table 19. North America Animal Therapeutics and Diagnostics Market, by Animal Type, 2020-2030, ($Million)
Table 20. North America Animal Therapeutics and Diagnostics Market, by Country, 2020-2030, ($Million)
Table 21. U.S. Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 22. U.S. Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 23. Canada Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 24. Canada Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 25. Mexico Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 26. Mexico Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 27. Europe Animal Therapeutics and Diagnostics Market, by Product Type, 2020-2030, ($Million)
Table 28. Europe Animal Therapeutics and Diagnostics Market, by Animal Type, 2020-2030, ($Million)
Table 29. Europe Animal Therapeutics and Diagnostics Market, by Country, 2020-2030, ($Million)
Table 30. Germany Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 31. Germany Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 32. France Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 33. France Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 34. U.K. Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 35. U.K. Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 36. Italy Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 37. Italy Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 38. Rest of Europe Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 39. Rest of Europe Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 40. Asia-Pacific Animal Therapeutics and Diagnostics Market, by Product Type, 2020-2030, ($Million)
Table 41. Asia-Pacific Animal Therapeutics and Diagnostics Market, by Animal Type, 2020-2030, ($Million)
Table 42. Asia-Pacific Animal Therapeutics and Diagnostics Market, by Country, 2020-2030, ($Million)
Table 43. China Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 44. China Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 45. India Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 46. India Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 47. Japan Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 48. Japan Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 49. South Korea Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 50. South Korea Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 51. Rest of Asia-Pacific Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 52. Rest of Asia-Pacific Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 53. LAMEA Animal Therapeutics and Diagnostics Market, by Product Type, 2020-2030, ($Million)
Table 54. LAMEA Animal Therapeutics and Diagnostics Market, by Animal Type, 2020-2030, ($Million)
Table 55. LAMEA Animal Therapeutics and Diagnostics Market, by Country, 2020-2030, ($Million)
Table 56. Latin America Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 57. Latin America Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 58. Middle East Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 59. Middle East Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 60. Africa Animal Therapeutics and Diagnostics Market by Product Type 2020-2030, ($Million)
Table 61. Africa Animal Therapeutics and Diagnostics Market by Animal Type 2020-2030, ($Million)
Table 62. Bayer Ag: Company Snapshot
Table 63. Bayer Ag: Operating Segments
Table 64. Bayer Ag: Product Portfolio
Table 65. Bayer Ag: Net Sales
Table 66. Bayer Ag: Key Stratergies
Table 67. Eli Lilly and Company: Company Snapshot
Table 68. Eli Lilly and Company: Operating Segments
Table 69. Eli Lilly and Company: Product Portfolio
Table 70. Eli Lilly and Company: Net Sales
Table 71. Eli Lilly and Company: Key Stratergies
Table 72. Boehringer: Company Snapshot
Table 73. Boehringer: Operating Segments
Table 74. Boehringer: Product Portfolio
Table 75. Boehringer: Net Sales
Table 76. Boehringer: Key Stratergies
Table 77. Ingelheim GmbH: Company Snapshot
Table 78. Ingelheim GmbH: Operating Segments
Table 79. Ingelheim GmbH: Product Portfolio
Table 80. Ingelheim GmbH: Net Sales
Table 81. Ingelheim GmbH: Key Stratergies
Table 82. Merck and Co.: Company Snapshot
Table 83. Merck and Co.: Operating Segments
Table 84. Merck and Co.: Product Portfolio
Table 85. Merck and Co.: Net Sales
Table 86. Merck and Co.: Key Stratergies
Table 87. Zoetis Inc.: Company Snapshot
Table 88. Zoetis Inc.: Operating Segments
Table 89. Zoetis Inc.: Product Portfolio
Table 90. Zoetis Inc.: Net Sales
Table 91. Zoetis Inc.: Key Stratergies
Table 92. Ceva Sante Animale: Company Snapshot
Table 93. Ceva Sante Animale: Operating Segments
Table 94. Ceva Sante Animale: Product Portfolio
Table 95. Ceva Sante Animale: Net Sales
Table 96. Ceva Sante Animale: Key Stratergies
Table 97. Sanofi S.A.: Company Snapshot
Table 98. Sanofi S.A.: Operating Segments
Table 99. Sanofi S.A.: Product Portfolio
Table 100. Sanofi S.A.: Net Sales
Table 101. Sanofi S.A.: Key Stratergies
Table 102. Nutreco N.V.: Company Snapshot
Table 103. Nutreco N.V.: Operating Segments
Table 104. Nutreco N.V.: Product Portfolio
Table 105. Nutreco N.V.: Net Sales
Table 106. Nutreco N.V.: Key Stratergies
Table 107. Virbac S.A.: Company Snapshot
Table 108. Virbac S.A.: Operating Segments
Table 109. Virbac S.A.: Product Portfolio
Table 110. Virbac S.A.: Net Sales
Table 111. Virbac S.A.: Key Stratergies
LIST OF FIGURES
Figure 1. Animal Therapeutics and Diagnostics Market Segmentation
Figure 2. Animal Therapeutics and Diagnostics Market, 2020-2030
Figure 3. Animal Therapeutics and Diagnostics Market, 2020-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Animal Therapeutics and Diagnostics Market:Drivers, Restraints and Opportunities
Figure 11. Animal Therapeutics and Diagnostics Market, by Product Type, 2020 (%)
Figure 12. Comparative Share Analysis of Animal Diagnostics Products Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 13. Comparative Share Analysis of Animal Therapeutics Products Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 14. Animal Therapeutics and Diagnostics Market, by Animal Type, 2020 (%)
Figure 15. Comparative Share Analysis of Companion Animals Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 16. Comparative Share Analysis of Cattle Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 17. Comparative Share Analysis of Pigs Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 18. Comparative Share Analysis of Poultry Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 19. Comparative Share Analysis of Sheep Animal Therapeutics and Diagnostics Market, 2020-2030 (%)
Figure 20. Animal Therapeutics and Diagnostics Market by Region, 2020
Figure 21. U.S. Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 22. Canada Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 23. Mexico Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 24. Germany Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 25. France Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 26. U.K. Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 27. Italy Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 28. Rest of Europe Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 29. China Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 30. India Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 31. Japan Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 32. South Korea Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 33. Rest of Asia-Pacific Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 34. Latin America Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 35. Middle East Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 36. Africa Animal Therapeutics and Diagnostics Market, 2020-2030 ($Million)
Figure 37. Top Winning Strategies, by Year
Figure 38. Top Winning Strategies, by Development
Figure 39. Top Winning Strategies, by Company
Figure 40. Product Mapping of Top 10 Players
Figure 41. Competitive Dashboard
Figure 42. Competitive Heatmap of Top 10 Key Players
Figure 43. Bayer AG.: Net Sales, ($Million)
Figure 44. Eli Lilly and Company.: Net Sales, ($Million)
Figure 45. Boehringer.: Net Sales, ($Million)
Figure 46. Ingelheim GmbH.: Net Sales, ($Million)
Figure 47. Merck and Co. Net Sales, ($Million)
Figure 48. Zoetis Inc. Net Sales, ($Million)
Figure 49. Ceva Sante Animale.: Net Sales, ($Million)
Figure 50. Sanofi SA.: Net Sales, ($Million)
Figure 51. Nutreco N.V. Net Sales, ($Million)
Figure 52. Virbac SA.: Net Sales, ($Million)

Executive Summary

According to this report titled, 'Animal Therapeutics and Diagnostics Market,' the animal therapeutics and diagnostics market size was valued at $33,462.50 million in 2020, and is estimated to reach $59.1 Billion by 2030, growing at a CAGR of 5.9% from 2021 to 2030. Animal diagnostics is critical for determining the source of any disease. It comprises a variety of equipment and consumables that can aid in illness diagnosis, while therapeutic medicines are effective in disease therapy due to their mode of action. Animal diagnostics include determining the conditions that cause disease development and transmission. Therapeutic solutions for the treatment of animals are made up of several medications that cure diseases in animals.

Diagnosis of an ailment is the most important component of management of any disease. Immediate diagnosis of any ailment in animals becomes essential to avoid transmission of that particular infection among animals. Animal diagnostics also plays an important role in examining the pathogen causing death in animals. Diagnosis of the cause of death of an animal is a crucial step to create a treatment plan for the animals, which are in immediate contact with deceased. A minor outbreak of disease can affect the entire population due to cross infections. Animal diagnostics have attained importance due to increase in the zoonotic infections and growth in the veterinary health diagnostics market.

Therapeutic and diagnostic products are used for treatment and identification of animal ailments respectively, and have witnessed a lot of advancements in the diagnostic procedures and therapeutic agents in the recent years. Developments in veterinary medicine has made the treatment and prevention of catastrophic animal health problems easier. The veterinary health diagnostics market for diagnostics and therapeutic products has experienced growth due to the increase in dependence of humans on animals for various reasons including food, companionship, and other products, such as leather.

The expansion of the global animal diagnostics market is fueled by increase in number of animals in emerging nations, surge in demand for animal-based products, and rise in adoption of companion animals. Furthermore, the animal diagnostics industry has shown moderate expansion in recent years, owning to alarming increase in prevalence of illnesses among livestock. Moreover, epidemic outbreaks result in massive animal loss of biodiversity, which is a key concern for companies that rely on farm animals for their products. In addition, zoonotic illnesses that afflict animals represent a hazard to human health, making disease identification and treatment a critical component of disease management.

Moreover, key players are focusing on disease curing solutions for animals such as cats and dogs. For instance, in January 2022, Elanco Animal Health Incorporated introduced Zorbium, buprenorphine transdermal solution for cats. ZORBIUM is a novel long-acting medicine for controlling postoperative pain in cats after surgical operations. A single transdermal dosage can offer pain relief for up to four days. Similarly, in June 2021, Elanco Animal Health introduced Tanovea for the treatment of lymphoma in dogs. As a result, introduction of solutions for pet animal is expected to provide lucrative growth in animal diagnostics market.

However, during the pandemic lockdown, various manufacturers in the animal diagnostics industry had to stop their businesses. This break directly impacted sales of animal therapeutics and diagnostics companies. In addition, lack of manpower and raw materials constricted supply of equipment of animal therapeutics and diagnostics, which negatively influenced the animal diagnostics industry growth. However, reopening of production facilities and introduction of vaccines for coronavirus disease are anticipated to lead to re-opening of animal therapeutics and diagnostics companies.

Key findings of the Study

  • The report provides an extensive analysis of the current and emerging animal therapeutics and diagnostics market trends and dynamics.
  • Depending on product type, the animal therapeutics products segment dominated the animal therapeutics and diagnostics market in terms of revenue in 2020, and is projected to grow at a significant CAGR during the forecast period.
  • By animal type, the cattle segment registered highest revenue in 2020.
  • North America is projected to register highest growth rate in the coming years.
  • The global animal therapeutics and diagnostics market forecast analysis from 2021 to 2030 is included in the report.
The key players within the veterinary health diagnostics market are profiled in this report, and their strategies are analyzed thoroughly, which help understand competitive outlook of the animal therapeutics and diagnostics industry.

The global animal therapeutics and diagnostics market share analysis from 2020 to 2030 is included in the report.

In-depth animal therapeutics and diagnostics market analysis is conducted by constructing estimations for the key segments between 2021 and 2030.

Companies Mentioned

  • Bayer AG
  • Eli Lilly and Company
  • Boehringer
  • Ingelheim GmbH
  • Merck and Co.
  • Zoetis Inc.
  • Ceva Sante Animale
  • Sanofi S.A.
  • Nutreco N.V.
  • Virbac S.A.

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedMarch 2022
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 33462.5 million
Forecasted Market Value ( USD ) by 2030 $ 59082.1 million
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030 - Product Image

Animal Pharmaceuticals Market by Type, Route of Administration, Application, End User - Global Forecast 2025-2030

  • Report
  • 189 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Veterinary Pharmaceuticals Market by Products, Animal Type, Mode of Administration, Indications, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Global Markets for Animal Therapeutics and Diagnostics - Product Image

Global Markets for Animal Therapeutics and Diagnostics

  • Report
  • 303 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.